Viatris Statistics
NASDAQ: VTRSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
17.35-0.145 (-0.83%)
Market open · Delayed 15 min · as of Oct 8, 2:21 PM ET
Viatris by the numbers
Viatris has a market capitalization of $19.92 billion based on 1.15B shares outstanding. With trailing EPS of $-0.36, Viatris is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 2.4% above its 50-day average and 12.6% above its 200-day average.
Average daily trading volume is 9.18M shares, or about $159.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
VTRS valuation vs. peer median
| Metric | VTRS | Peer median | Difference |
|---|---|---|---|
| Market cap | $19.92B | $18.27B | +9% |
| Forward P/E | 6.5 | 22.2 | -71% |
| Avg. volume | 9.18M | 1.93M | +375% |
Peer median across 8 companies: INSM, GMAB, UTHR, ROIV, ASND, JAZZ, SMMT, CORT.
Valuation
- Market cap
- $19.92B
- Forward P/E
- 6.49
- Price / sales (latest FY)
- 1.39
- EPS (TTM)
- $-0.36
- Shares outstanding
- 1.15B
Price and trading
- Previous close
- 17.49
- Open
- 17.26
- Day range
- 16.89 – 17.44
- 52-week range
- 9.69 – 18.43
- 52-week change
- +72.49%
- Beta
- —
- Volume
- 8.45M
- Average volume
- 9.18M
Dividends and events
- Annual dividend
- $0.48
- Dividend yield
- 2.77%
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 19.92B
- Forward Pe
- 6.49
- Eps
- -0.36
- Dividend Yield
- 2.74%
- Dividend Rate
- 0.48
- Week52 High
- 18.43
- Week52 Low
- 9.69
- Avg Volume
- 9.18M
- Shares Outstanding
- 1.15B
- Ma50
- 16.94
- Ma200
- 15.41
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -5.89%
- Pct From52w Low
- 79.00%